Related references
Note: Only part of the references are listed.geoBoundaries: A global database of political administrative boundaries
Daniel Runfola et al.
PLOS ONE (2020)
Introducing new vaccines in low- and middle-income countries: challenges and approaches
Adrienne Guignard et al.
EXPERT REVIEW OF VACCINES (2019)
Long-term incidence of severe malaria following RTS, S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial
Halidou Tinto et al.
LANCET INFECTIOUS DISEASES (2019)
malariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project
Daniel A. Pfeffer et al.
MALARIA JOURNAL (2018)
Vaccination Challenges in Confronting the Resurgent Threat From Yellow Fever
Lin H. Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan
Lucy A. Parker et al.
LANCET INFECTIOUS DISEASES (2017)
Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys
Adam Bennett et al.
LANCET GLOBAL HEALTH (2017)
Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020
Sachiko Ozawa et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2017)
Fractional dosing of yellow fever vaccine to extend supply: a modelling study
Joseph T. Wu et al.
LANCET (2016)
Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
Melissa A. Penny et al.
LANCET (2016)
Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study
Jamie T. Griffi et al.
LANCET INFECTIOUS DISEASES (2016)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Michael T. White et al.
LANCET INFECTIOUS DISEASES (2015)
The contribution of vaccination to global health: past, present and future
Brian Greenwood
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection
Michael T. White et al.
PLOS ONE (2013)
The imperative for stronger vaccine supply and logistics systems
Michel Zaffran et al.
VACCINE (2013)
Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies
Jamie T. Griffin et al.
PLOS MEDICINE (2010)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Share Paper
